
Anti-presbyopia drops - are we there yet?
When I wrote a review of anti-presbyopia drops in December 2021’s issue, I felt sure we were soon to be swamped with myriad pharmaceuticals – real and cloned – to rid us of one of life’s greatest inconveniences: the dreaded presbyopia. Strangely, that does not appear to have happened – I have not he










